We report the time units used to build adoption trends: raw adoption log data of both datasets have a more fine grained time-scales as specified in dataset description.
a glutamate groups (GLUs): PC12 cells received 5 mM glutamate and then maintained for 24 h.b AGS-IV groups (AGS-IVs): PC12 cells were treated with 50 μM AGS-IV for 6 h before exposure to 5 mM glutamat
Operational definition for fatigue and associated factors among adult cancer patients receiving cancer treatment at oncology unit in Amhara region, Ethiopia, 2022.
